Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VVOSthis companyVivos Therapeutics, Inc.	$0.10	-0.99×	-14×	1.2×	-1.62×	-32523.0%	60.4%	-114.1%	-121.7%	1424.8%	-123.1%	-84.4%	-9.06×	-0.58×	0×	0.24×	0.0%	3	-11.29	2	C
ADGMAdagio Medical Holdings, Inc.	$1.90	-0.69×	1.39×	0×	-1.03×	-386.4%	0.0%	0.0%	0.0%	-202.3%	-62.2%	-112.5%	1.75×	-0.22×	-7.53×	2.44×	0.0%	1	-6.71	2	C
AEMDAethlon Medical, Inc.	$5.34	-1.03×	1.51×	0×	-0.39×	21.8%	0.0%	0.0%	0.0%	-146.4%	-139.6%	-95.0%	0.07×	0.69×	-507.49×	3.85×	0.0%	1	-40.86	3	B-
AMSAmerican Shared Hospital Services	$1.24	-9.17×	0.58×	0.5×	8.14×	182.4%	18.0%	-7.2%	-5.5%	-6.5%	-3.4%	-32.5%	0.94×	4.71×	-1.28×	0.76×	0.0%	4	0.59	2	C
COCHEnvoy Medical, Inc.	$7.39	-0.54×	-1.31×	63.8×	-0.57×	-96.7%	-262.7%	-9240.7%	-9857.3%	201.9%	786.9%	-119.5%	-0.08×	0.13×	-14.01×	0.54×	11.8%	3	-20.16	1	C-
CODXCo-Diagnostics, Inc.	$0.27	-0.14×	0.33×	10.83×	0.08×	1999.8%	64.3%	-5025.5%	-7533.6%	-227.3%	-138.3%	-442.4%	0.06×	0.22×	0×	3.87×	0.0%	2	-17.12	3	B-
Peer median	—	-0.69×	0.58×	0.5×	-0.39×	21.8%	0.0%	-7.2%	-5.5%	-146.4%	-62.2%	-112.5%	0.07×	0.22×	-7.53×	2.44×	0.0%	2	-17.12	2	—